St. Jude Children's Research Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
16 trials changed in the last 30 days: 0 stopped, 11 with notable changes, 5 with minor changes only.
- Notable: Real World Asparaginase Therapy Toxicity Recruitment opened
- Minor: Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders Study completion pushed from Dec 2026 to May 2027
- Notable: MAST · Molecular Analysis Of Solid Tumors Primary completion pushed from Sep 30, 2026 to Sep 30, 2030
- Notable: Patient-Reported Outcomes and Quality of Life in Adult and Pediatric · Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Primary completion pushed from Dec 31, 2026 to Feb 2029
- Notable: Stigma Healing Inventory Evaluation Recruitment opened
- Notable: Universal Newborn Screening For Sickle Cell Disease In Mozambique Recruitment opened
- Notable: Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma Start date pushed from Oct 2026 to Dec 2026
- Notable: Delayed Effects Of Pediatric Car T Cell Therapy Primary completion pushed from Mar 2027 to Jan 2029
- Notable: Positron Emission Tomography (PET) Imaging of Reactive Oxygen and Nitrogen Species: Human Observation of Retention and Safety of [18F]-Fluoroedaravone Start date pushed from Oct 2026 to Dec 2026
- Notable: Acceptability of Remote Saliva Collection Start date pushed from Oct 2026 to Dec 2026
- Minor: B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy · Newly Diagnosed High-Risk Osteosarcoma Start date changed from estimate of Sep 2026 to Aug 21, 2026
- Notable: Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors Primary and study completion pushed from Dec 2026 to Dec 2027
- Notable: Using Bioimpedance Analysis to Monitor Fluid Status in Children Recruitment opened
- Minor: Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult · Refractory or Relapsed Acute Myeloid Leukemia Primary completion pushed from Oct 2026 to Jan 2027
- Minor: Liver Biopsy Following Gene Therapy For Hemophilia Start date pushed from Oct 2026 to Nov 2026
- Minor: Registry of Cases of Spinal Muscular Atrophy Start date pushed from Oct 2026 to Nov 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-17 | NCT07941531 T-Cell Therapy Using CD7 Negative T-Cells Expressing CD7 CAR Expressed In Pediatric… | Phase 1 | Not Yet Recruiting |
| 2026-11-04 | NCT07916389 Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 4 | |
| Phase 1 | 18 | |
| Phase 1/2 | 10 | |
| Phase 2 | 39 | |
| Phase 2/3 | 2 | |
| Phase 4 | 1 |
Not charted: 82 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 25
Leukemia (39) · Acute Lymphoblastic Leukemia (ALL) (31) · Sickle Cell Disease (17) · Sarcoma (14) · Hodgkin Lymphoma (13) · Acute Myeloid Leukemia (AML) (12) · Glioma (12) · Myelodysplastic Syndromes (MDS) (8) · Non-Hodgkin Lymphoma (7) · Melanoma (4)
Get alerts when St. Jude Children's Research Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.